✦ LIBER ✦

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder

✍ Scribed by Christopher Blick; Peter Hall; Thinn Pwint; Faisal Al-Terkait; Jeremy Crew; Thomas Powles; Valentine Macaulay; Nicholas Munro; David Douglas; Neviana Kilbey; Andrew Protheroe; John D. Chester

Book ID: 112066997
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 359 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.26675

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant methotrexate, vinblastine, d

Neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin for locally advanced transitional cell carcinoma of the bladder

✍ Ralph J. Miller Jr.; Robert R. Bahnson; Barbara Banner; Marc S. Ernstoff; Walter 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB 👁 2 views

Neoadjuvant m-vac (methotrexate, vinblas

Neoadjuvant m-vac (methotrexate, vinblastine, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of the bladder

✍ Cora N. Sternberg; Maria G. Arena; Federico Calabresi; Piero De Carli; Andrea Pl 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 747 KB

Methotrexate, vinblastine, doxorubicin a

Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy

✍ Han, K S; Joung, J Y; Kim, T S; Jeong, I G; Seo, H K; Chung, J; Lee, K H 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB

Long-Term results of neoadjuvant treatme

Long-Term results of neoadjuvant treatment with M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for locally invasive transitional cell carcinoma of the urothelium

✍ H. Miyake; Kazuo Gohji; Isao Hara; Hiroshi Eto; Kazuki Yamanaka; Soichi Arakawa; 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 68 KB

Treatment options for muscle-invasive ur

Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin : Report of Southwest Oncology Group Trial 8733

✍ Celestia S. Higano; Catherine M. Tangen; Wael A. Sakr; James Faulkner; Saul E. R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

## Abstract ## BACKGROUND. Many patients with invasive urothelial cell cancer are poor candidates for cisplatin‐based chemotherapy, and many are high risk for cystectomy. Southwest Oncology Group Trial 8733 was designed to address treatment for such patients. ## METHODS. Eligible patients had pr